UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for targeting tumors that have long resisted treatment.
A new preclinical study shows that red blood cells can be tagged in vivo and used as long-lasting carriers for imaging agents ...